Lapatinib Instructions for Use

Lapatinib, as an innovative anti-cancer drug, has brought new treatment hope to many breast cancer patients. In order to ensure that you can use this drug correctly and safely, the following is a detailed introduction to the indications, mechanism of action, usage and dosage of lapatinib, and possible side effects.

1. Indications

Lapatinib is mainly used to treat certain types of breast cancer. When used in combination with capecitabine, it is indicated for patients with advanced breast cancer who have been treated with other chemotherapy drugs. In addition, lapatinib also demonstrated significant efficacy when combined with letrozole in postmenopausal women whose disease has spread to other parts of the body.

2. Mechanism of action

Lapatinib is a 4-anilinoquinazoline kinase inhibitor that can effectively inhibit epidermal growth factor receptor (HER1/EGFR/ERBB1) and the intracellular tyrosine kinase domain of human epidermal growth factor receptor 2 type (HER2/ERBB2). This inhibitory effect can last for a long time, and its dissociation half-life reaches or exceeds 300 minutes. Lapatinib successfully inhibited tumor cell growth driven by ERBB in in vitro experiments and various animal models.

3. Usage and dosage

For HER2-positive metastatic breast cancer, the recommended dose of lapatinib is 1250 mg, taken orally once daily from day 1 to day 21. At the same time, capecitabine needs to be used in combination, the dose is 2000mg/m²/day, divided into two oral administrations, each time about 12 hours apart, from the 1 day to the 14 day. Combination therapy with these two drugs should be administered in a repeated 21-day cycle. Importantly, lapatinib should be taken at least one hour before or one hour after a meal, and the daily dose should be taken in one go; divided doses are not recommended.

For hormone receptor-positive, HER2-positive metastatic breast cancer, the recommended dose of lapatinib is 1500mg, taken orally once daily in combination with letrozole. The recommended dose of letrozole is 2.5 mg once daily. Likewise, lapatinib should be taken one hour before or after a meal, and the daily dose should be taken as a single dose.

4. Interactions and side effects

During the use of lapatinib, patients should pay special attention to interactions with other drugs. Drugs such as cimetidine, dexamethasone, and rifabutin may interact with lapatinib and affect the therapeutic effect. Therefore, before using lapatinib, be sure to tell your doctor about all the medicines you are taking.

In addition, lapatinib may cause a range of side effects. Severe allergic reactions such as hives and difficulty breathing, as well as severe skin problems such as fever and sore throat, require immediate medical attention. At the same time, lapatinib may also cause liver problems, such as upper abdominal pain, darker urine, etc. Once these symptoms occur, please contact your doctor immediately. Other common side effects include indigestion, nausea, vomiting, diarrhea, etc. Although these side effects are usually mild, you still need to pay close attention and communicate with your doctor in time.

5. Precautions and Storage

Lapatinib has the potential to cause serious or life-threatening liver injury, so liver function should be monitored regularly during use. Patients who have had liver disease should specifically inform their doctor before using lapatinib. In addition, the storage of the drug is also crucial. Lapatinib should be stored at a temperature of 20°C to 25°C and allowed to vary within the range of 15°C to 30°C. Make sure the medicine is stored out of the reach of children.

In short, lapatinib, as an effective anticancer drug, provides a new treatment option for breast cancer patients. However, during use, patients need to strictly follow the doctor's instructions, pay close attention to body reactions, and communicate with the doctor in a timely manner to ensure the safety and effectiveness of the treatment.

xa0

Reference materials:https://www.rxlist.com/tykerb-drug.htm#side_effects